180 related articles for article (PubMed ID: 16623833)
1. MPTP treatment of common marmosets impairs proteasomal enzyme activity and decreases expression of structural and regulatory elements of the 26S proteasome.
Zeng BY; Iravani MM; Lin ST; Irifune M; Kuoppamäki M; Al-Barghouthy G; Smith L; Jackson MJ; Rose S; Medhurst AD; Jenner P
Eur J Neurosci; 2006 Apr; 23(7):1766-74. PubMed ID: 16623833
[TBL] [Abstract][Full Text] [Related]
2. A comparison of changes in proteasomal subunit expression in the substantia nigra in Parkinson's disease, multiple system atrophy and progressive supranuclear palsy.
Bukhatwa S; Zeng BY; Rose S; Jenner P
Brain Res; 2010 Apr; 1326():174-83. PubMed ID: 20176003
[TBL] [Abstract][Full Text] [Related]
3. Proteasomal activity in brain differs between species and brain regions and changes with age.
Zeng BY; Medhurst AD; Jackson M; Rose S; Jenner P
Mech Ageing Dev; 2005; 126(6-7):760-6. PubMed ID: 15888331
[TBL] [Abstract][Full Text] [Related]
4. A modified MPTP treatment regime produces reproducible partial nigrostriatal lesions in common marmosets.
Iravani MM; Syed E; Jackson MJ; Johnston LC; Smith LA; Jenner P
Eur J Neurosci; 2005 Feb; 21(4):841-54. PubMed ID: 15787691
[TBL] [Abstract][Full Text] [Related]
5. Proteomic analysis of the neuroprotective mechanisms of acupuncture treatment in a Parkinson's disease mouse model.
Jeon S; Kim YJ; Kim ST; Moon W; Chae Y; Kang M; Chung MY; Lee H; Hong MS; Chung JH; Joh TH; Lee H; Park HJ
Proteomics; 2008 Nov; 8(22):4822-32. PubMed ID: 18942673
[TBL] [Abstract][Full Text] [Related]
6. Pramipexole protects against MPTP toxicity in non-human primates.
Iravani MM; Haddon CO; Cooper JM; Jenner P; Schapira AH
J Neurochem; 2006 Mar; 96(5):1315-21. PubMed ID: 16464239
[TBL] [Abstract][Full Text] [Related]
7. Microsomal epoxide hydrolase deletion enhances tyrosine hydroxylase phosphorylation in mice after MPTP treatment.
Liu M; Hunter R; Nguyen XV; Kim HC; Bing G
J Neurosci Res; 2008 Sep; 86(12):2792-801. PubMed ID: 18500758
[TBL] [Abstract][Full Text] [Related]
8. Olfactory impairment and Parkinson's disease-like symptoms observed in the common marmoset following administration of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine.
Miwa T; Watanabe A; Mitsumoto Y; Furukawa M; Fukushima N; Moriizumi T
Acta Otolaryngol Suppl; 2004 Aug; (553):80-4. PubMed ID: 15277042
[TBL] [Abstract][Full Text] [Related]
9. Increased expression and altered subunit composition of proteasomes induced by continuous proteasome inhibition establish apoptosis resistance and hyperproliferation of Burkitt lymphoma cells.
Fuchs D; Berges C; Opelz G; Daniel V; Naujokat C
J Cell Biochem; 2008 Jan; 103(1):270-83. PubMed ID: 17516511
[TBL] [Abstract][Full Text] [Related]
10. Gene expression profiling in progressively MPTP-lesioned macaques reveals molecular pathways associated with sporadic Parkinson's disease.
Ohnuki T; Nakamura A; Okuyama S; Nakamura S
Brain Res; 2010 Jul; 1346():26-42. PubMed ID: 20513370
[TBL] [Abstract][Full Text] [Related]
11. Alteration of dopaminergic markers in gastrointestinal tract of different rodent models of Parkinson's disease.
Tian YM; Chen X; Luo DZ; Zhang XH; Xue H; Zheng LF; Yang N; Wang XM; Zhu JX
Neuroscience; 2008 May; 153(3):634-44. PubMed ID: 18420351
[TBL] [Abstract][Full Text] [Related]
12. Exploring the neuroprotective effects of modafinil in a marmoset Parkinson model with immunohistochemistry, magnetic resonance imaging and spectroscopy.
van Vliet SA; Blezer EL; Jongsma MJ; Vanwersch RA; Olivier B; Philippens IH
Brain Res; 2008 Jan; 1189():219-28. PubMed ID: 18076869
[TBL] [Abstract][Full Text] [Related]
13. Damage to the nigrostriatal system in the MPTP-treated SAMP8 mouse.
Liu J; Wang YY; Liu L; Wang QD; Yuan ZY; Zhang ZX; Gu P; Wang MW
Neurosci Lett; 2008 Dec; 448(2):184-8. PubMed ID: 18977411
[TBL] [Abstract][Full Text] [Related]
14. The pattern of neuronal loss and survival may reflect differential expression of proteasome activators in Parkinson's disease.
McNaught KS; Jnobaptiste R; Jackson T; Jengelley TA
Synapse; 2010 Mar; 64(3):241-50. PubMed ID: 19924695
[TBL] [Abstract][Full Text] [Related]
15. Phosphorylation of 20S proteasome alpha subunit C8 (alpha7) stabilizes the 26S proteasome and plays a role in the regulation of proteasome complexes by gamma-interferon.
Bose S; Stratford FL; Broadfoot KI; Mason GG; Rivett AJ
Biochem J; 2004 Feb; 378(Pt 1):177-84. PubMed ID: 14583091
[TBL] [Abstract][Full Text] [Related]
16. Alterations in lysosomal and proteasomal markers in Parkinson's disease: relationship to alpha-synuclein inclusions.
Chu Y; Dodiya H; Aebischer P; Olanow CW; Kordower JH
Neurobiol Dis; 2009 Sep; 35(3):385-98. PubMed ID: 19505575
[TBL] [Abstract][Full Text] [Related]
17. Hyperphosphorylation of rat liver proteasome subunits: the effects of ethanol and okadaic acid are compared.
Bardag-Gorce F; Venkatesh R; Li J; French BA; French SW
Life Sci; 2004 Jun; 75(5):585-97. PubMed ID: 15158368
[TBL] [Abstract][Full Text] [Related]
18. Mapping the murine cardiac 26S proteasome complexes.
Gomes AV; Zong C; Edmondson RD; Li X; Stefani E; Zhang J; Jones RC; Thyparambil S; Wang GW; Qiao X; Bardag-Gorce F; Ping P
Circ Res; 2006 Aug; 99(4):362-71. PubMed ID: 16857966
[TBL] [Abstract][Full Text] [Related]
19. Upregulation of guanylyl cyclase expression and activity in striatum of MPTP-induced parkinsonism in mice.
Chalimoniuk M; Langfort J; Lukacova N; Marsala J
Biochem Biophys Res Commun; 2004 Nov; 324(1):118-26. PubMed ID: 15464991
[TBL] [Abstract][Full Text] [Related]
20. Proteasome subunits are regulated and expressed in comparable concentrations as a functional cluster.
Sato Y; Sakamoto K; Sei M; Ewis AA; Nakahori Y
Biochem Biophys Res Commun; 2009 Jan; 378(4):795-8. PubMed ID: 19063865
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
